Ligand Pharmaceuticals Incorporated (LGND)
LGND trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$303.53
-2.44% on the day
Market cap
$6.1B
Mid cap
Revenue · 2025
$268.1M
+60.4% on 2024
Net income · 2025
$124.5M
46.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LGND on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000886163 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $268.1M |
| Net income | $124.5M |
| Operating income | $41.0M |
| Net margin | 46.4% |
| Operating margin | 15.3% |
| Revenue growth | +60.4% |
| Cash | $174.9M |
| Total assets | $1.6B |
| P/E (computed) | 48.6× |
| P/S (computed) | 22.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-02-27 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-09-24 |
| Latest proxy | DEFA14A | 2026-05-18 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.6% |
| 1 month | +6.5% |
| 3 months | -0.5% |
| Year to date | +56.0% |
| 1 year | +64.0% |
| From 52-week high | -8.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BLTE | Belite Bio Inc | $151.87 | -4.24% | $6.1B |
| KNSA | Kiniksa Pharmaceuticals International plc | $78.53 | -0.90% | $6.1B |
| RYTM | Rhythm Pharmaceuticals Inc. | $86.61 | -3.57% | $6.0B |
| ALKS | Alkermes plc | $39.73 | -1.32% | $6.7B |
| PRAX | Praxis Precision Medicines Inc. | $243.34 | -3.20% | $6.8B |
| AMRX | Amneal Pharmaceuticals Inc. | $19.57 | -2.30% | $6.8B |
| IONS | Ionis Pharmaceuticals Inc. | $42.38 | -2.95% | $7.0B |
| MIRM | Mirum Pharmaceuticals Inc. | $79.62 | -7.48% | $5.2B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier